Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
1.
Indian Pediatr ; 2019 May; 56(5): 387-390
Article | IMSEAR | ID: sea-199332

ABSTRACT

Objective: To find the relationship between Helicobacter pylori infection and iron deficiencyanemia in school-aged children. Methods: 71children with dyspepsia, epigastric and vagueabdominal pain attending a tertiary medical center in Iran underwent upper gastrointestinalendoscopy and were investigated for H. Pylori infection. Hemoglobin, mean corpuscularvolume (MCV), serum ferritin, total iron binding capacity (TIBC) and serum iron levels werecompared between children with or without H. pylori infection. Results: H. pylori infection wasdetected in 42 (59.1%) patients. Proportion of children with iron deficiency anemia was notstatistically different between two groups (26.2% vs. 14.3%; P=0.48). While hemoglobin wassignificantly lower in children with H. pylori infection (P=0.01), there were no significantdifferences in serum level of ferritin, iron, mean corpuscular volume and total iron bindingcapacity. Conclusion: Presence of H. pylori does not seem to play an important role in thepathophysiology and development of iron deficiency anemia in school-aged Iranianpopulation

2.
São Paulo med. j ; 131(3): 166-172, 2013. tab
Article in English | LILACS | ID: lil-679559

ABSTRACT

CONTEXT AND OBJECTIVE Patients with beta-thalassemia major (β-TM) experience physical, psychological and social problems that lead to decreased quality of life (QoL). The aim here was to measure health-related QoL and its determinants among patients with β-TM, using the Short Form-36 (SF-36) questionnaire. DESIGN AND SETTING Cross-sectional study at the Hematology Research Center of Shiraz University of Medical Sciences, in southern Iran. METHODS One hundred and one patients with β-TM were randomly selected. After the participants' demographics and disease characteristics had been recorded, they were asked to fill out the SF-36 questionnaire. The correlations of clinical and demographic factors with the QoL score were evaluated. RESULTS There were 44 men and 57 women of mean age 19.52 ± 4.3 years (range 12-38). On two scales, pain (P = 0.041) and emotional role (P = 0.009), the women showed significantly lower scores than the men. Lower income, poor compliance with iron-chelating therapy and presence of comorbidities were significantly correlated with lower SF-36 scores. These factors were also found to be determinants of worse SF-36 scores in multivariate analysis. CONCLUSIONS We showed that the presence of disease complications, poor compliance with iron-chelating therapy and poor economic status were predictors of worse QoL among patients with β-TM. Prevention and proper management of disease-related complications, increased knowledge among patients regarding the importance of managing comorbidities and greater compliance with iron-chelating therapy, along with psychosocial and financial support, could help these patients to cope better with this chronic disease state. .


CONTEXTO E OBJETIVO Pacientes com beta-talassemia maior (β-TM) vivenciam problemas físicos, psicológicos e sociais que levam à diminuição da qualidade de vida (QV). O objetivo foi determinar a QV relacionada à saúde e seus determinantes em pacientes com β-TM, utilizando questionário SF-36 (Short Form-36). TIPO DE ESTUDO E LOCAL Estudo transversal no Centro de Hematologia e Pesquisa em Universidade de Ciências Médicas de Shiraz, no sul do Irã. MÉTODOS Foram selecionados aleatoriamente 101 pacientes com β-TM. Após registro demográfico e características da doença, eles foram convidados a preencher o questionário SF-36. A correlação entre fatores clínicos e demográficos com escore de QV foi avaliada. RESULTADOS Havia 44 homens e 57 mulheres, com idade média de 19,52 ± 4,3 (variação 12-38) anos. Em duas escalas, dor (P = 0,041) e aspectos emocionais (P = 0,009), as mulheres apresentaram escores significativamente menores aos dos homens. Menor renda, baixa adesão à terapia quelante de ferro e presença de comorbidades foram correlacionadas com escores SF-36 significativamente menores. Esses fatores foram também considerados determinantes de piores escores de SF-36 em análise multivariada. CONCLUSÕES Mostramos que a presença de complicações da doença, a baixa adesão ao tratamento da terapia quelante de ferro e o baixo status econômico são preditores de pior QV em pacientes com β-TM. Prevenção e manejo adequado das complicações relacionadas com a doença, aumento do conhecimento dos pacientes sobre a importância do gerenciamento de comorbidades e ter maior adesão ao tratamento quelante de ferro, considerando também ...


Subject(s)
Adolescent , Adult , Child , Female , Humans , Male , Young Adult , Quality of Life , Surveys and Questionnaires , beta-Thalassemia , Epidemiologic Methods , Iran/epidemiology , Iron Chelating Agents/therapeutic use , Medication Adherence/statistics & numerical data , Socioeconomic Factors , beta-Thalassemia/complications , beta-Thalassemia/drug therapy , beta-Thalassemia/psychology
4.
Indian Pediatr ; 2007 Jan; 44(1): 29-32
Article in English | IMSEAR | ID: sea-9721

ABSTRACT

OBJECTIVE: This study was conducted to assess bone mineral density (BMD) and bone mineral content (BMC) in patients with thalassemia major and intermedia, and to correlate them with biochemical and hematological profile. DESIGN: 106 thalassemic patients (49 major and 57 intermedia) were scanned by dual energy xray absorptiometry technique for BMD and BMC at lumbar spine and femoral neck. The effects of sex, transfusion/chelation program as well as hemoglobin, calcium, phosphorus, alkaline phosphatase and serum ferritin level were also evaluated on BMD and BMC. RESULTS: Patients with thalassemia major and intermedia, younger than 20 yr, showed lower BMD and BMC in the lumbar region (p < 0.05). Both parameters correlated significantly with hemoglobin level; other biochemical and hematological parameters did not influence BMD and BMC values. CONCLUSION: Bone marrow density is a good index of bone status in patients with Thalassemia and should be done in these patients annually.


Subject(s)
Adult , Bone Density , Child , Comorbidity , Female , Humans , India/epidemiology , Male , Osteoporosis/epidemiology , beta-Thalassemia/epidemiology
SELECTION OF CITATIONS
SEARCH DETAIL